LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Home・Aktien・Edwards Lifesciences Corp

Edwards Lifesciences Corp

Open

Branche Gesundheitswesen

69.13 0.83

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

68.56

Max

70.94

Schlüsselkennzahlen
By Trading Economics
Einkommen	14M 366M
Verkäufe	30M 1.6B
KGV Branchendurchschnitt	39.81 103.001
EPS	0.7
Gewinnspanne	22.472
Angestellte	19,800
EBITDA	-59M 417M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+15.29 upside

Dividenden
By Dow Jones
Nächstes Ergebnis	23. Okt. 2024

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-289M 42B
Vorheriger Eröffnungskurs	68.3
Vorheriger Schlusskurs	69.13

Nachrichtenstimmung

By Acuity

38%

62%

74 / 365 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

68.24 / 69.92 Unterstützung & Widerstand

Edwards Lifesciences Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

15. Juli 2024, 13:57 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences to Buy Innovalve for $300 Million

3. Sept. 2024, 20:38 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

3. Sept. 2024, 20:37 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

3. Sept. 2024, 20:36 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

25. Juli 2024, 09:02 UTC

Ergebnisse

Heiße Aktien

Stocks to Watch Thursday: Ford, IBM, Chipotle, American Airlines -- WSJ

25. Juli 2024, 08:40 UTC

Peer-Vergleich

Kursveränderung

Edwards Lifesciences Corp Prognose

Kursziel

By TipRanks

15.29% Vorteil

12-Monats-Prognose

Durchschnitt 79 USD 15.29%

Hoch 91 USD

Tief 70 USD

Basierend auf 23 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Edwards Lifesciences Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

23 ratings

Buy

Halten

Sell

Basierend auf 23 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Edwards Lifesciences Corp – Dist abgegeben haben.

Technischer Score

By Trading Central

68.24 / 69.92Unterstützung & Widerstand

Bearish events outweigh bullish events.

The bullish and bearish events are balanced.

All events are bearish.

Stimmung

By Acuity

74 / 365 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

EBITDA

Betriebsergebnis

Über Edwards Lifesciences Corp

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease. Its Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.